Dosimetria interna de radioinmunoterapia: consideraciones generales

Dechebal Gil de Montes, Alberto; González González, Joaquin; Oliva, Juan P; Baum, Richard P.
Rev. med. nucl. Alasbimn j ; 3(9)oct. 2000.
Artículo en Español | LILACS | ID: lil-270939

Documentos relacionados

  1. Why bother with alpha particles?
  2. Dosimetria interna de radioinmunoterapia: consideraciones generales
  3. Alpha and Beta Radiation for Theragnostics.
  4. Targeted α-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies.
  5. Radionuclides for radioimmunotherapy: criteria for selection.
  6. The best radionuclide for radioimmunotherapy of small tumors: beta- or alpha-emitter?
  7. [Proposal and Analysis of "Ternary" Model of Sensitization for Proton Therapy].
  8. Comparison between Targeted Radionuclide Therapy of Bone Metastases Based on ß-Emitting and α-Emitting Radionuclides.
  9. Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
  10. An overview of targeted alpha therapy.